ZIM Laboratories Limited (ZIMLAB.BO)
INR 113.15
(0.85%)
INR 113.15
(0.85%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.67 Billion | 3.94 Billion | 3.3 Billion | 2.94 Billion | 2.61 Billion | 3.26 Billion |
| Cost of Revenue | 2.4 Billion | 1.99 Billion | 1.61 Billion | 1.59 Billion | 1.44 Billion | 1.6 Billion |
| Gross Profit | 1.26 Billion | 1.94 Billion | 1.69 Billion | 1.35 Billion | 1.16 Billion | 1.66 Billion |
| Operating Expenses | 1.01 Billion | 1.59 Billion | 1.44 Billion | 1.1 Billion | 1.06 Billion | 1.34 Billion |
| Selling, General and Administrative Expenses | 357.29 Million | 410.59 Million | 445.84 Million | 364.04 Million | 309.26 Million | 548.66 Million |
| Research and Development Expenses | - | 187.38 Million | 168.74 Million | 138.66 Million | 145.17 Million | 153.08 Million |
| Other Expenses | 655.75 Million | 4.39 Million | 1.76 Million | 1.73 Million | 2.08 Million | 2.48 Million |
| Cost and Expenses | 3.42 Billion | 3.58 Billion | 3.05 Billion | 2.69 Billion | 2.51 Billion | 2.95 Billion |
| Operating Income | 253.82 Million | 310.82 Million | 224.56 Million | 117.13 Million | 38.84 Million | 224.12 Million |
| Interest Expense | 69.24 Million | 49.7 Million | 71.69 Million | 95.1 Million | 113.3 Million | 87.47 Million |
| Income Tax Expense | 63.96 Million | 109.2 Million | 64.92 Million | 29.13 Million | -32.28 Million | 67.28 Million |
| Earnings before Tax | 236.42 Million | 353.55 Million | 210.42 Million | 102.31 Million | 686 Thousand | 220.7 Million |
| Net Income | 172.46 Million | 244.34 Million | 145.5 Million | 73.17 Million | 32.96 Million | 153.41 Million |
| Earnings Per Share Basic | 3.54 | 5.01 | 2.99 | 1.50 | 0.68 | 3.17 |
| Earnings Per Share Diluted | 3.54 | 5.01 | 2.99 | 1.50 | 0.68 | 3.15 |
| Weighted Average Shares Outstanding | 48.71 Million | 48.72 Million | 48.72 Million | 48.68 Million | 48.52 Million | 48.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.71 Million | 48.72 Million | 48.72 Million | 48.68 Million | 48.69 Million | 48.69 Million |
| Gross Margin | 0.34 | 0.49 | 0.51 | 0.46 | 0.45 | 0.51 |
| EBIT Margin | 0.13 | 0.15 | 0.13 | 0.14 | 0.10 | 0.13 |
| Profit Margin | 0.05 | 0.06 | 0.04 | 0.02 | 0.01 | 0.05 |
| EBITDA | 462.09 Million | 582 Million | 452.62 Million | 368.92 Million | 258.11 Million | 438.99 Million |
| Earnings Before Tax Margin | 0.07 | 0.08 | 0.07 | 0.04 | 0.01 | 0.07 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 818.24 Million | 1.17 Billion | 3.67 Billion | 962.92 Million | 858.26 Million | 674.42 Million |
| Cost of Revenue | 556.82 Million | 748.07 Million | 2.4 Billion | 442.16 Million | 399.19 Million | 311.14 Million |
| Gross Profit | 261.41 Million | 430.55 Million | 1.26 Billion | 520.76 Million | 459.06 Million | 363.28 Million |
| Operating Expenses | 230.47 Million | 313.13 Million | 1.01 Billion | 444.78 Million | 406.67 Million | 355.24 Million |
| Selling, General and Administrative Expenses | 230.47 Million | 313.13 Million | - | 273.71 Million | 237.55 Million | 188.65 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 9.98 Million | 15.34 Million | 51.83 Million | 11.12 Million | 14.21 Million | 11.15 Million |
| Cost and Expenses | 787.3 Million | 1.06 Billion | 3.42 Billion | 886.94 Million | 805.87 Million | 666.38 Million |
| Operating Income | 30.94 Million | 117.42 Million | 253.82 Million | 75.97 Million | 52.38 Million | 8.04 Million |
| Interest Expense | 28.58 Million | 22.77 Million | 69.24 Million | 16.96 Million | 12.16 Million | 17.34 Million |
| Income Tax Expense | 3.36 Million | 29.14 Million | 63.96 Million | 22.29 Million | 12.93 Million | -412 Thousand |
| Earnings before Tax | 12.34 Million | 109.99 Million | 236.42 Million | 70.14 Million | 54.43 Million | 1.85 Million |
| Net Income | 8.98 Million | 80.85 Million | 172.46 Million | 47.84 Million | 41.49 Million | 2.26 Million |
| Earnings Per Share Basic | 0.18 | 1.66 | - | 0.98 | 0.85 | 0.05 |
| Earnings Per Share Diluted | 0.18 | 1.66 | - | 0.98 | 0.85 | 0.05 |
| Weighted Average Shares Outstanding | 48.72 Million | 48.72 Million | 48.71 Million | 48.72 Million | 48.72 Million | 48.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.72 Million | 48.72 Million | 48.71 Million | 48.72 Million | 48.72 Million | 48.72 Million |
| Gross Margin | 0.32 | 0.37 | 0.34 | 0.54 | 0.53 | 0.54 |
| EBIT Margin | 0.10 | 0.13 | - | 0.13 | 0.13 | 0.09 |
| Profit Margin | 0.01 | 0.07 | 0.05 | 0.05 | 0.05 | 0.00 |
| EBITDA | 80.36 Million | 156.47 Million | - | 126.45 Million | 107.45 Million | 59.45 Million |
| Earnings Before Tax Margin | 0.04 | 0.10 | 0.07 | 0.08 | 0.06 | 0.01 |
OVZON
0922
VLE
036630
BIOIF
ANRG